COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review
Maryam Sharifian, Mohammad Ali Sahraian, Giulia Fadda, Michael Osherov, Amirhossein Sharifian-Dorche, Maryam Karaminia, Alexander Saveriano, Roberta La Piana, Jack P. Antel, Paul S. Giacomini
Topics & Concepts
MedicineNeuromyelitis opticaMultiple sclerosisDemyelinating diseaseRituximabPandemicDiseaseCoronavirus disease 2019 (COVID-19)Demyelinating DisorderNatalizumabIntensive care medicinePediatricsImmunologyInternal medicineInfectious disease (medical specialty)AntibodyMultiple Sclerosis Research StudiesLong-Term Effects of COVID-19Peripheral Neuropathies and Disorders